Literature DB >> 32296902

[Plasma circulating tumor HPV-DNA as a potential biomarker to identify recurrence of HPV-associated oropharyngeal carcinoma].

Alexander Rühle1,2, Nils H Nicolay3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32296902     DOI： 10.1007/s00066-020-01618-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.

Authors:  Tanguy Y Seiwert; Barbara Burtness; Ranee Mehra; Jared Weiss; Raanan Berger; Joseph Paul Eder; Karl Heath; Terrill McClanahan; Jared Lunceford; Christine Gause; Jonathan D Cheng; Laura Q Chow
Journal:  Lancet Oncol       Date:  2016-05-27       Impact factor: 41.316

2.  Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.

Authors:  Bhishamjit S Chera; Sunil Kumar; Brian T Beaty; David Marron; Stuart Jefferys; Rebecca Green; Emily C Goldman; Robert Amdur; Nathan Sheets; Roi Dagan; D Neil Hayes; Jared Weiss; Juneko E Grilley-Olson; Adam Zanation; Trevor Hackman; Jeffrey M Blumberg; Samip Patel; Mark Weissler; Xianming M Tan; Joel S Parker; William Mendenhall; Gaorav P Gupta
Journal:  Clin Cancer Res       Date:  2019-05-14       Impact factor: 12.531

3.  Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.

Authors:  Shao Hui Huang; Bayardo Perez-Ordonez; Fei-Fei Liu; John Waldron; Jolie Ringash; Jonathan Irish; Bernard Cummings; Lillian L Siu; John Kim; Ilan Weinreb; Andrew Hope; Patrick Gullane; Dale Brown; Willa Shi; Brian O'Sullivan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

4.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Authors:  Robert L Ferris; George Blumenschein; Jerome Fayette; Joel Guigay; A Dimitrios Colevas; Lisa Licitra; Kevin Harrington; Stefan Kasper; Everett E Vokes; Caroline Even; Francis Worden; Nabil F Saba; Lara C Iglesias Docampo; Robert Haddad; Tamara Rordorf; Naomi Kiyota; Makoto Tahara; Manish Monga; Mark Lynch; William J Geese; Justin Kopit; James W Shaw; Maura L Gillison
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

5.  Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Authors:  Carole Fakhry; Amanda L Blackford; Geoff Neuner; Weihong Xiao; Bo Jiang; Amit Agrawal; Maura L Gillison
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

6.  Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.

Authors:  Bhishamjit S Chera; Sunil Kumar; Colette Shen; Robert Amdur; Roi Dagan; Rebecca Green; Emily Goldman; Jared Weiss; Juneko Grilley-Olson; Shetal Patel; Adam Zanation; Trevor Hackman; Jeff Blumberg; Samip Patel; Brian Thorp; Mark Weissler; Wendell Yarbrough; Nathan Sheets; William Mendenhall; Xianming M Tan; Gaorav P Gupta
Journal:  J Clin Oncol       Date:  2020-02-04       Impact factor: 44.544

7.  HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.

Authors:  Jian Wang; Hao Sun; Qin Zeng; Xue-Jun Guo; Hui Wang; Huan-Huan Liu; Zhong-Yi Dong
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.